Tigecycline salvage therapy for necrotizing fasciitis caused by Vibrio vulnificus: Case report in a child

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 1, 2016, Pages 138-141

  Lin, Yu San ^a   Hung, Min Hsiang ^a   Chen, Chi Chung ^a,b   Huang, Kuo Feng ^a   Ko, Wen Chien ^c   Tang, Hung Jen ^a,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Child; Necrotizing fasciitis; Tigecycline; Vibrio vulnificus

Indexed keywords

C REACTIVE PROTEIN; CEFPIROME; CEFTAZIDIME; HEMOGLOBIN; MINOCYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT;

ACHILLES TENDON; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE; BREATHING RATE; CASE REPORT; CHILD; CHILDHOOD DISEASE; DEBRIDEMENT; EMERGENCY SURGERY; ERYTHEMA; FASCIOTOMY; FEVER; FREE SKIN GRAFT; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOCOMPROMIZED PATIENT; IN VITRO STUDY; INGUINAL REGION; LEG INJURY; LEG SWELLING; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NECROTIZING FASCIITIS; NEUTROPHIL COUNT; NONHUMAN; PHYSICAL EXAMINATION; PULSE RATE; SALVAGE THERAPY; SCHOOL CHILD; SHOCK; SKIN DISCOLORATION; SPLIT THICKNESS SKIN GRAFT; THROMBOCYTE COUNT; TREATMENT RESPONSE; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION; ANALOGS AND DERIVATIVES; FASCIITIS, NECROTIZING; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; TREATMENT OUTCOME; VIBRIO INFECTIONS;

ANTI-BACTERIAL AGENTS; CHILD; DEBRIDEMENT; FASCIITIS, NECROTIZING; HUMANS; MALE; MINOCYCLINE; SALVAGE THERAPY; TREATMENT OUTCOME; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 84958050232     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.04.008     Document Type: Article

References (12)

1. Wang S.C., Lin K.H., Chern J.P., Lu M.Y., Jou S.T., Lin D.T., et al. Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin Infect Dis 2003, 37:984-988.
2. Miron D., Lev A., Colodner R., Merzel Y. Vibrio vulnificus necrotizing fasciitis of the calf presenting with compartment syndrome. Pediatr Infect Dis J 2003, 22:666-668.
3. Chiu S., Chiu C.H., Jaing T.H., Chang K.J., Lin T.Y. Necrotising fasciitis caused by Vibrio vulnificus in a child without known risk factors. Eur J Pediatr 2002, 161:464-465.
4. Woo M.L., Patrick W.G., Simon M.T., French G.L. Necrotising fasciitis caused by Vibrio vulnificus. J Clin Pathol 1984, 37:1301-1304.
5. Wang S.M., Liu C.C., Chiou Y.Y., Yang H.B., Chen C.T. Vibrio vulnificus infection complicated by acute respiratory distress syndrome in a child with nephrotic syndrome. Pediatr Pulmonol 2000, 29:400-403.
6. Chen S.C., Lee Y.T., Tsai S.J., Chan K.S., Chao W.N., Wang P.H., et al. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother 2012, 67:488-493.
7. Liu C.Y., Huang Y.T., Liao C.H., Hsueh P.R. In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan. Antimicrob Agents Chemother 2008, 52:2677-2679.
8. Reygaert W.C. Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline. Ther Clin Risk Manag 2010, 6:419-430.
9. Oberholzer A., Oberholzer C., Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96.
10. Kloppenburg M., Brinkman B.M., de Rooij-Dijk H.H., Miltenburg A.M., Daha M.R., Breedveld F.C., et al. The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob Agents Chemother 1996, 40:934-940.
11. Chiang S.R., Tang H.J., Chang P.C., Cheng K.C., Ko W.C., Chen C.H., et al. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection. J Microbiol Immunol Infect 2007, 40:123-133.
12. Saliba R., Paasch L., El Solh A. Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol 2009, 31:583-588.